European Heart Journal Open, 2023 Circulating proteins and peripheral artery disease risk: observational and Mendelian randomization analyses Yuan S., Titova O., Zhang K. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Microbiome, 2023 Gut microbiota, circulating inflammatory markers and metabolites, and carotid artery atherosclerosis in HIV infection Wang Z., Peters B., Bryant M. et al. Olink Target 96CVDInfectious DiseasesPathophysiologySerum | | | | |
Biomedicines, 2023 Controlled Attenuation Parameter Is Associated with a Distinct Systemic Inflammatory Milieu after Clearance of HCV Infection Du Y., Khera T., Liu Z. et al. Olink Target 96Infectious DiseasesHepatologyPathophysiologyPlasma | | | | |
JNCI: Journal of the National Cancer Institute, 2023 Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools Feng X., Wu W., Onwuka J. et al. Olink Target 96OncologyPatient StratificationPlasmaSerum | | | | |
eBioMedicine, 2023 Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis Feng X., Muller D., Zahed H. et al. Olink Target 96OncologyPatient StratificationBlood | | | | |
Environment International, 2023 Plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with altered levels of proteins previously linked to inflammation, metabolism and cardiovascular disease Dunder L., Salihovic S., Lind P. et al. Olink Target 96Environmental Health & ToxicologyPathophysiologyPlasma | | | | |
Frontiers in Molecular Neuroscience, 2023 Olink proteomics profiling platform reveals non-invasive inflammatory related protein biomarkers in autism spectrum disorder Bao X., Chen B., Liu J. et al. Olink Target 96NeurologyPatient StratificationPlasma | | | | |
Cell Reports Medicine, 2023 Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients Diray-Arce J., Fourati S., Doni Jayavelu N. et al. Olink Target 96Infectious DiseasesPathophysiologySerum | | | | |
American Journal of Physiology-Heart and Circulatory Physiology, 2023 Characterization of a robust mouse model of heart failure with preserved ejection fraction Matsiukevich D., Kovacs A., Li T. et al. Olink Target 96 MouseCVDPathophysiologySerum | | | | |
Circulation: Heart Failure, 2023 Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study Girerd N., Levy D., Duarte K. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Scandinavian Journal of Medicine & Science in Sports, 2023 Association of muscular strength and targeted proteomics involved in brain health in children with overweight/obesity Olvera‐Rojas M., Plaza‐Florido A., Solis‐Urra P. et al. Olink Target 96Metabolic DiseasesNeurologyPathophysiologyPlasma | | | | |
Scientific Reports, 2023 Metagenomic sequencing of human cardiac tissue reveals Microbial RNA which correlates with Toll-like receptor-associated inflammation in patients with heart disease Sandstedt J., Vukusic K., Dellgren G. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
, 2023 Delineating the effect of sex hormone intake on immunity in cis and trans women with HIV Pasin C., Nuñez D., Kusejko K. et al. Olink Target 96Immunological & Inflammatory DiseasesInfectious DiseasesPatient StratificationPlasma | | | | |
Neurobiology of Disease, 2023 Uncovering a neurological protein signature for severe COVID-19 El-Agnaf O., Bensmail I., Al-Nesf M. et al. Olink Target 96NeurologyInfectious DiseasesPathophysiologyPatient StratificationPlasma | | | | |
Clinical Rheumatology, 2023 Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+ dermatomyositis Zhang P., Li M., Zhang Y. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma | | | | |
Journal of Clinical Immunology, 2023 Insights into the expanding intestinal phenotypic spectrum of SOCS1 haploinsufficiency and therapeutic options Rodari M., Cazals-Hatem D., Uzzan M. et al. Olink Target 48Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
The American Journal of Human Genetics, 2023 Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the “omnigenic” sparse effector hypothesis of complex trait genetics Iakovliev A., McGurnaghan S., Hayward C. et al. Olink Target 96Metabolic DiseasesPathophysiologyPlasma | | | | |
Frontiers in Immunology, 2023 Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies Li M., Zhang Y., Zhang W. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Thrombosis Research, 2023 Unsupervised clustering of venous thromboembolism patients by clinical features at presentation identifies novel endotypes that improve prognostic stratification Pallares Robles A., ten Cate V., Lenz M. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |
Scientific Reports, 2023 Age-dependent differences and similarities in the plasma proteomic signature of postoperative delirium Oren R., Kim E., Leonard A. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma | | | | |